AirSculpt Technologies (AIRS) vs Concord Medical Services (CCM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Concord Medical Services (CCM) has outperformed AirSculpt Technologies (AIRS) over the past year, losing 1.4% versus a loss of 83.9%. Over five years, CCM leads with a -85.0% price change compared with -95.1% for AIRS. AirSculpt Technologies is the larger company by market cap ($43.7 million vs $15.4 million), about 2.8 times the size, while Concord Medical Services is growing revenue faster (+25.2% vs -15.8%).
AirSculpt Technologies converts more of its revenue into profit, with a net margin of -7.7% versus -20.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIRS | CCM |
|---|---|---|
| Share price | $0.5907 | $3.55 |
| Market cap | $43.67M | $15.41M |
| 1-day change | -9.72% | -1.11% |
| YTD return | -70.17% | -8.03% |
| 1-year return | -83.86% | -1.39% |
| 5-year return | -95.10% | -84.96% |
| EPS (TTM) | $-0.12 | $-2.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $151.82M | $65.85M |
| Revenue growth (YoY) | -15.82% | +25.19% |
| Net income (latest FY) | $-11.67M | $-13.27M |
| Gross margin | 59.37% | 5.61% |
| Operating margin | -7.61% | -56.78% |
| Net margin | -7.68% | -20.15% |
| 52-week high | $5.79 | $6.80 |
| 52-week low | $0.516 | $2.79 |
| Distance from 52-week high | -89.80% | -47.79% |
| Analyst consensus | none | — |
| Avg. price target upside | +661.81% | — |
| Average volume | 1.27M | 21.48K |
| Shares outstanding | 73.93M | 2.82M |
| Employees | 330 | 610 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AirSculpt Technologies is about 2.8 times larger than Concord Medical Services by market value ($43.67M vs $15.41M).
- CCM has outperformed AIRS by 82.5 percentage points over the past year.
- AirSculpt Technologies is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -20.2 cents for Concord Medical Services.
- Concord Medical Services grew revenue faster in its latest fiscal year (+25.19% vs -15.82%).
About AirSculpt Technologies
AIRS stock →AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Health Care · Medical/Nursing Services · 330 employees
About Concord Medical Services
CCM stock →Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital.
Health Care · Medical/Nursing Services · 610 employees
AIRS vs CCM FAQ
Which is bigger, AirSculpt Technologies or Concord Medical Services?
AirSculpt Technologies (AIRS) is larger, with a market capitalization of $43.67M compared with $15.41M for Concord Medical Services (CCM).
Which stock has performed better over the past year, AIRS or CCM?
CCM returned -1.39% over the past 12 months, compared with -83.86% for AIRS (price return, excluding dividends). Past performance does not predict future results.
Are AirSculpt Technologies and Concord Medical Services in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.